Carrie M. Mosher, Ph.D.
|2008||University of Washington, Seattle, Seattle, WA|
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Bratton SM, Mosher CM, Khallouki F, et al. (2012) Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases. The Journal of Pharmacology and Experimental Therapeutics. 340: 46-55|
|Mosher CM, Court MH. (2010) Comparative and veterinary pharmacogenomics. Handbook of Experimental Pharmacology. 49-77|
|Mosher CM, Tai G, Rettie AE. (2009) CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistry. The Journal of Pharmacology and Experimental Therapeutics. 329: 938-44|
|Mosher CM, Hummel MA, Tracy TS, et al. (2008) Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9. Biochemistry. 47: 11725-34|
|Hummel MA, Locuson CW, Gannett PM, et al. (2005) CYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant. Molecular Pharmacology. 68: 644-51|